Literature DB >> 15310460

Lessons from models of SOD1-linked familial ALS.

Caterina Bendotti1, Maria Teresa Carrì.   

Abstract

Ten years ago, the linkage between mutations in the gene coding for the antioxidant enzyme Cu,Zn superoxide dismutase (SOD1) and the neurodegenerative disease known as familial amyotrophic lateral sclerosis (FALS) was established. This finding has prompted a myriad of new studies in experimental models aimed at investigating the toxic function of the mutant enzymes. The cellular functions that are impaired in motoneurons as a consequence of molecular alterations induced by the expression of FALS SOD1 converge on pathways that might be activated in sporadic ALS by other toxic factors. Recent data demonstrate that, although motoneurons are lost in patients, other cell types are also affected and actively contribute to the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15310460     DOI: 10.1016/j.molmed.2004.06.009

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  51 in total

Review 1.  Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis.

Authors:  Lee J Martin
Journal:  IDrugs       Date:  2010-08

Review 2.  Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis.

Authors:  Jason R Thonhoff; Luis Ojeda; Ping Wu
Journal:  Curr Stem Cell Res Ther       Date:  2009-09       Impact factor: 3.828

3.  Corticospinal motor neurons and related subcerebral projection neurons undergo early and specific neurodegeneration in hSOD1G⁹³A transgenic ALS mice.

Authors:  P Hande Ozdinler; Susanna Benn; Ted H Yamamoto; Mine Güzel; Robert H Brown; Jeffrey D Macklis
Journal:  J Neurosci       Date:  2011-03-16       Impact factor: 6.167

Review 4.  Alsin and the molecular pathways of amyotrophic lateral sclerosis.

Authors:  Jayanth Chandran; Jinhui Ding; Huaibin Cai
Journal:  Mol Neurobiol       Date:  2007-07-10       Impact factor: 5.590

Review 5.  Functional polymorphisms of the brain serotonin synthesizing enzyme tryptophan hydroxylase-2.

Authors:  X Zhang; J-M Beaulieu; R R Gainetdinov; M G Caron
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

6.  Species-dependent neuropathology in transgenic SOD1 pigs.

Authors:  Huaqiang Yang; Guohao Wang; Haitao Sun; Runzhe Shu; Tao Liu; Chuan-En Wang; Zhaoming Liu; Yu Zhao; Bentian Zhao; Zhen Ouyang; Dongshan Yang; Jiao Huang; Yueling Zhou; Shihua Li; Xiaodan Jiang; Zhicheng Xiao; Xiao-Jiang Li; Liangxue Lai
Journal:  Cell Res       Date:  2014-02-28       Impact factor: 25.617

7.  Inducible nitric oxide synthase is present in motor neuron mitochondria and Schwann cells and contributes to disease mechanisms in ALS mice.

Authors:  Kevin Chen; Frances J Northington; Lee J Martin
Journal:  Brain Struct Funct       Date:  2009-11-04       Impact factor: 3.270

8.  Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria.

Authors:  Christine Vande Velde; Timothy M Miller; Neil R Cashman; Don W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-22       Impact factor: 11.205

9.  The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice.

Authors:  Lee J Martin; Barry Gertz; Yan Pan; Ann C Price; Jeffery D Molkentin; Qing Chang
Journal:  Exp Neurol       Date:  2009-03-09       Impact factor: 5.330

10.  Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis.

Authors:  Claudia Pitzer; Carola Krüger; Christian Plaas; Friederike Kirsch; Tanjew Dittgen; Ralph Müller; Rico Laage; Stefan Kastner; Stefanie Suess; Robert Spoelgen; Alexandre Henriques; Hannelore Ehrenreich; Wolf-Rüdiger Schäbitz; Alfred Bach; Armin Schneider
Journal:  Brain       Date:  2008-10-03       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.